How do we avoid carrying duplicate MRO data into the next ERP state?
Healthcare Systems buyers do not search for generic AI transformation when the operating problem is live. They search for evidence around pre-migration material master cleanup: how large the issue is, which owners should review it, and whether it can be proven without a long ERP or consulting project.
The Force Team view is that ERP migrations expose catalog debt that site teams tolerated for years; the first step is a bounded duplicate diagnostic before migration design locks. In Healthcare Systems, the relevant asset context is hospital facilities, biomedical support, generators, HVAC, pumps, clinical engineering stores, and multi-site campuses. The language that wins attention is not abstract automation; it is capital exposure, downtime risk, procurement leakage, and governance readiness translated into finance, operations, procurement, and CIO governance terms.
The buyer committee usually includes CIO / ERP Transformation Lead, maintenance or reliability ownership, procurement, master-data governance, and finance. Each role needs a different proof layer: duplicate-family evidence for operations, exposure values for finance, supplier and item fragmentation for procurement, and no-write-back control for technology leadership.
PartsCleanse AI is positioned as the first product path because it produces evidence from a CSV export. It does not ask Healthcare Systems teams to approve a platform before they know the size of the opportunity. The diagnostic identifies duplicate records, separates high-confidence findings from specialist-review cases, and turns 4 - into a decision-ready report.
The practical next step is not to debate AI in principle. It is to run a diagnostic on the current catalog, review the findings by confidence tier, and decide whether the value is material enough for remediation, governance, or a larger AI adoption workstream.
